An integrated approach to the implementation of the stage of pulmonary rehabilitation of patients with chronic obstructive pulmonary disease: the importance of lifestyle modification
https://doi.org/10.17650/1818-8338-2023-17-1-K689
Abstract
Aim. To evaluate the effectiveness of an integrated approach to the implementation of the outpatient stage of rehabilitation of patients with chronic obstructive pulmonary disease (COPD) after outpatient treatment of moderate exacerbation. Materials and methods. The analysis of the effectiveness of 100 programs of the outpatient stage of rehabilitation of COPD patients who have suffered an exacerbation of moderate severity with the inclusion of the stage of correction of risk factors, physical therapy and physiotherapy procedures was carried out. The effectiveness was evaluated with the determination of high-speed indicators, the severity of shortness of breath according to the modified Medical Research Council Scale (mMRC) questionnaire and the Borg's scale, the level of blood oxygen saturation, body mass index, the six-minute walk test and the BODE index (Body-mass index, airflow Obstruction, Dyspnea, and Exercise). In order to assess the impact of the outpatient stage of rehabilitation on the quality of life, in addition to using the MOS SF-36 questionnaire and COPD Assessment Test (CAT), tests were conducted to assess the global health status and quality of treatment by the patient and the doctor. Results. In patients of the clinical observation group with mandatory inclusion of lifestyle modification (complete cessation of smoking and the use of alternative methods of nicotine delivery), 4 weeks after the beginning of the outpatient stage of pulmonary rehabilitation, there was a tendency to increase the maximum volumetric flow rate (MOS) at the level of 50 (p = 0.078) and 75 % (p1 = 0.061, p2 = 0.085) from the forced vital capacity of the lungs, the severity of dyspnea on the mMRC scale decreased by 18.6 % (p = 0.03); exercise tolerance improved - by 10.2 % on the Borg's scale (p < 0.01), by 4.9 % on the six-minute walk test (p < 0.01); the BODE (Body-mass index, airflow Obstruction, Dyspnea, and Exercise) index decreased by 31.7 % (p < 0.01). In both subgroups of the clinical observation group, there was a statistically significant improvement in quality of life indicators characterizing the state of physical health: physical functioning, role functioning and the total level of physical health; as well as indicators characterizing mental health indicators: vitality and social functioning (at p < 0.05) Conclusion. The effectiveness of an integrated approach to the implementation of the outpatient stage of rehabilitation of COPD patients who have suffered an exacerbation of moderate severity, with the inclusion of mandatory lifestyle modification (smoking cessation and the use of alternative techniques), physiotherapeutic methods of treatment (medicinal electrophoresis on the chest area) and methods of physical rehabilitation. Pulmonary rehabilitation of COPD patients with mandatory correction of risk factors, both during remission and during exacerbation, should be carried out in a planned form within the framework of primary health care to the population, primarily determining the quality of life of patients. |
Keywords
chronic obstructive pulmonary disease,
outpatient stage of pulmonary rehabilitation,
physical methods of treatment,
quality of life,
quitting smoking traditional cigarettes,
lifestyle modification,
alternative methods of combating smoking,
physical health,
mental health,
exacerbation of moderate severity
Supporting agencies: The study was conducted within the framework of the research work of the Rostov State Medical University, Ministry of Health of Russia.
About the Author
T. V. Tayutina
Rostov State Medical University, Ministry of Health of Russia
Russian Federation
Russian Federation
Tatiana Vladimirovna Tayutina
29 Nakhichevan Lane, Rostov-on-Don 344022
References
1. . Pulmonology. National leadership. Short edition. Chuchalin A.G. editor. M.: GEOTAR-Media; 2016.
2. Tayutina T.V., Bagmet A.D., Nedashkovskaya N.G. Chronic obstructive pulmonary disease in the structure of pulmonological pathology of Rostov Region. Klinicheskaya medicina = Clinical Medicine 2020;98(1):56-60. (In Russ.). DOI: 10.34651/0023¬2149-2020-98-1-56-60
3. Mukharlyamov M.Yu., Sycheva M.G., Rassulova M.A., Razumov A.N. Pulmonary rehabilitation: novel programmes and perspectives. Pul'monologiya = Pulmonology 2013;(6):99—105. (In Russ.). DOI: 10.18093/0869-0189-2013-0-6-99-105
4. Jen R., Rennard S.I., Sin D.D. Effects of inhaled corticosteroids on airway inflammation in chronic obstructive pulmonary disease: a systematic review and metaanalysis. Int J Chron Obstruct Pulmon Dis 2012;7:587-95. DOI: 10.2147/COPD.S32765
5. Tayutina T.V., Bagmet A.D., Lysenko A.V. et al. Clinical and functional features of chronic obstructive pulmonary disease in elderly patients in the Rostov region. Uspechi gerontologii = Successes of gerontology 2021;34(1):84-89. (In Russ.). DOI: 10.34922/AE.2021.34.1.011
6. Polosa R., Campagna D., Caponnetto P. What to advise to respiratory patients intending to use electronic cigarettes. Discov Med 2015;20(109):155-61. PMID: 26463097
7. Rabinovich R.A., Louvaris Z., Raste Y. et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 2013;42(5):1205-15. DOI: 10.1183/09031936.00134312
8. Santos C., Santos J., Morais L. et al. Pulmonary rehabilitation in COPD: Effects of two aerobic exercise intensity in patient centered outcomes - a randomized study (Abstract). Chest 2011;140(4 Suppl):853A. DOI: 10.1378/chest.1119544
9. Farsalinos K.E., Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf 2014;5(2):67-86. DOI: 10.1177/2042098614524430
10. Farsalinos K.E., Romagna G., Tsiapras D. et al. Characteristics, perceived side effects and benefits of electronic cigarette use: a world-wide survey of more than 19000 consumers. Int J Environ Res Public Health 2014;11(4):4356-73. DOI: 10.3390/ijerph110404356
11. Sutherland E.R., Crapo J.D., Bowler R.P. N-acetylcysteine and exacerbations of chronic obstructive pulmonary disease. COPD 2006;3(4):195-202. DOI: 10.1080/15412550600977361
12. Polosa R., Morjaria J., Prosperini U. et al. Health outcomes in COPD smokers using heated tobacco products: a 3year followup. Intern Emerg Med 2021;16(3):687-96. DOI: 10.1007/s11739-021-02674-3
13. Steer J., Gibson J., Bourke S.C. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 2012;67(11):970-6. DOI: 10.1136/thoraxjnl-2012-202103
14. Suissa S., Dell'Aniello S., Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax 2012;67(11):957-63. DOI: 10.1136/thoraxjnl-2011-201518
15. Vestbo J., Hurd S.S., Agust A.G. et al. Global strategy for the diag¬nosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347-65. DOI: 10.1164/rccm.201204-0596PP
Review
For citations:
Tayutina T.V. An integrated approach to the implementation of the stage of pulmonary rehabilitation of patients with chronic obstructive pulmonary disease: the importance of lifestyle modification. The Clinician. 2023;17(1):28-38. (In Russ.) https://doi.org/10.17650/1818-8338-2023-17-1-K689
Views:
304
Email this article 